Announced Sat, 4 Jul · 16:21 IST
Board okays capital reduction, new director, pet healthcare entry
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.0%1-day move
₹11.90
prior close
₹11.93
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+6.0+10.0+7.7+13.1+15.1+21.9+0.9———
Up moveDown movePending
AI summary
Samsrita Labs board approved: (1) appointment of Mr. Ravikanth Chopperla as Additional Non-Executive Director holding 7.1% stake; (2) capital reduction to cancel 1,13,74,855 equity shares (50% of capital) to set off accumulated losses and share premium of 11.58 crore — shareholder percentages unchanged, no cash paid; (3) entry into pet animal healthcare; (4) related party deals with associate QROPS Advisory Services. Capital reduction needs NCLT and shareholder nod. AGM on August 10, 2026.
Likely market impact
Capital reduction is technical and does not change economic interest; pending NCLT and shareholder approval.